-
Statin-treated patients who developed symptoms of myopathy should be treated with at least 100 mg daily of coenzyme Q10 for a minimum of 30 days (assuming CPK values and/or other liver function tests are not abnormal) before discontinuing statin therapy.
-
The FDA has approved the first continuous, low dose, oral contraceptive for the prevention of pregnancy.
-
Almost 90% of persons with type 2 diabetes (DM2) are overweight. Weight loss in DM2 consistently results in meaningful favorable changes in lipids, glucose, and insulin resistance, so the clinical community embraces tools to enhance weight loss in this population.
-
In this article, the ECG in the Figure was obtained from a 33-year old man who was admitted to the hospital with atypical chest pain.
-
Limiting dietary sodium can reduce blood pressure and morbidity and mortality from cardiovascular disease.
-
In a systematic review and meta-analysis of worldwide data on the placement of ureteral stents after ureteroscopy in patients with kidney stones, the authors found higher morbidity with lower urinary tract problems ...
-
This study documents the safety and efficacy of oral polyethylene glycol for the long-term treatment of chronic constipation.
-
GlaxoSmithKline's rosiglitazone (Avandia) will receive a black box warning by the FDA because of concerns over heart failure associated with use of the drug.
-
Results from past research studies have investigated a possible relationship between hormonal contraceptive use and HIV acquisition, but understanding remained poor due to inconsistent results and shortfalls in study design.
-
When it comes to initiating oral contraceptives (OCs), new research indicates that immediate initiation before start of the next menses improves short-term continuation of pill use.
